Articles citing this paper
The Design of Drugs that Target Tumour Hypoxia
William A. Denny A
+ Author Affiliations
- Author Affiliations
A Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland, New Zealand (e-mail: b.denny@auckland.ac.nz).
Bill Denny received his Ph.D. and D.Sc. degrees in chemistry from the University of Auckland, where he is director of the Auckland Cancer Society Research Center. He has participated in the development of seven anticancer drugs to clinical trials. His currect research interests include signal transduction inhibitors and hypoxia-activated prodrugs. |
Australian Journal of Chemistry 57(9) 821-828 https://doi.org/10.1071/CH04051
Submitted: 1 March 2004 Accepted: 19 April 2004 Published: 1 September 2004
15 articles found in Crossref database.
Transporter and protease mediated delivery of platinum complexes for precision oncology
Hambley Trevor W.
JBIC Journal of Biological Inorganic Chemistry. 2019 24(4). p.457
Copper and zinc bis(thiosemicarbazonato) complexes with a fluorescent tag: synthesis, radiolabelling with copper-64, cell uptake and fluorescence studies
Lim SinChun,
Price Katherine A.,
Chong Siow-Feng,
Paterson Brett M.,
Caragounis Aphrodite,
Barnham Kevin J.,
Crouch Peter J.,
Peach Josephine M.,
Dilworth Jonathan R.,
White Anthony R., Donnelly Paul S.
JBIC Journal of Biological Inorganic Chemistry. 2010 15(2). p.225
Is Anticancer Drug Development Heading in the Right Direction?
Hambley Trevor W.
Cancer Research. 2009 69(4). p.1259
Development of a Reduction‐Responsive Amino Acid that Induces Peptide Bond Cleavage in Hypoxic Cells
Shigenaga Akira,
Ogura Keiji,
Hirakawa Hiroko,
Yamamoto Jun,
Ebisuno Koji,
Miyamoto Licht,
Ishizawa Keisuke,
Tsuchiya Koichiro, Otaka Akira
ChemBioChem. 2012 13(7). p.968
Radiation- and Photo-induced Activation of 5-Fluorouracil Prodrugs as a Strategy for the Selective Treatment of Solid Tumors
Ito Takeo,
Tanabe Kazuhito,
Yamada Hisatsugu,
Hatta Hiroshi, Nishimoto Sei-ichi
Molecules. 2008 13(10). p.2370
Physiological Targeting to Improve Anticancer Drug Selectivity
Hambley Trevor W.
Australian Journal of Chemistry. 2008 61(9). p.647
Hypoxia-targeted bioreductive tyrosine kinase inhibitors with glutathione-depleting function
Sarangarajan Rangaprasad,
Apte Shireesh P., Ugwu Sydney O.
Anti-Cancer Drugs. 2006 17(1). p.21
Application of Hybrid Organic/Inorganic Dendritic ABA Type Triblock Copolymers as New Nanocarriers in Drug Delivery Systems
Namazi Hassan, Jafarirad Saeed
International Journal of Polymeric Materials. 2011 60(9). p.603
The Design of Drugs that Target Tumor Hypoxia.
Denny William A.
ChemInform. 2004 35(52).
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones
Bonnitcha Paul D.,
Kim Byung J.,
Hocking Rosalie K.,
Clegg Jack K.,
Turner Peter,
Neville Suzanne M., Hambley Trevor W.
Dalton Transactions. 2012 41(37). p.11293
Synthesis and Evaluation of Novel Dendrimers with a Hydrophilic Interior as Nanocarriers for Drug Delivery
Dhanikula Renu Singh, Hildgen Patrice
Bioconjugate Chemistry. 2006 17(1). p.29
Synthesis and structure–activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs
Hu Longqin,
Wu Xinghua,
Han Jiye,
Chen Lin,
Vass Simon O.,
Browne Patrick,
Hall Belinda S.,
Bot Christopher,
Gobalakrishnapillai Vithurshaa,
Searle Peter F.,
Knox Richard J., Wilkinson Shane R.
Bioorganic & Medicinal Chemistry Letters. 2011 21(13). p.3986
Chemistry at the Interface
Abell Andrew D.
Australian Journal of Chemistry. 2004 57(9). p.819
Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) – Potential combination agents for the PET imaging of hypoxia
Bonnitcha Paul D.,
Bayly Simon R.,
Theobald Mark B.M.,
Betts Helen M.,
Lewis Jason S., Dilworth Jonathan R.
Journal of Inorganic Biochemistry. 2010 104(2). p.126
Bioreductive Drugs: from Concept to Clinic
McKeown S.R.,
Cowen R.L., Williams K.J.
Clinical Oncology. 2007 19(6). p.427
